Listen to The Big Take on iHeart, Apple Podcasts, Spotify.
Startups pioneering invasive and noninvasive devices that interact with the brain seek to alleviate everything from ALS symptoms to epilepsy to treatment-resistant depression. In this episode, a look at the science behind this rapidly advancing technology.Dr. Thomas Oxley, a neurointerventionist and CEO of Synchron, gives us a tour of his lab in Brooklyn, New York, where his company is developing an implant that allows paralyzed people to control devices. 
Then Bloomberg reporter Sarah McBride joins Wes for a look at other startups making these brain-computer interfaces–and where the industry goes from here. 
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK 
Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.This podcast is produced by the Big Take Podcast team: Supervising Producer: Vicki Vergolina, Senior Producer: Kathryn Fink, Producers: Mo Barrow, Rebecca Chaisson, Michael Falero and Federica Romaniello, Associate Producers: Sam Gebauer and Zaynab Siddiqui. Sound Design/Engineers: Raphael Amsili and Gilda Garcia.See omnystudio.com/listener for privacy information.